Vimarsana
Biggest News Aggregation in the World

Page 17 - Postpartum Support News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Postpartum Support. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Postpartum Support Today - Breaking & Trending Today

How to Work From Home With a Sick Child - Vimarsana News

How to Work From Home With a Sick Child

Trying to work when your child is home sick can feel like an impossible task, but experts say it can be done — if you give yourself and your kid

Hey Parents — How To Prepare For The Period After Baby Is Born - Vimarsana News

Hey Parents — How To Prepare For The Period After Baby Is Born

Plus, the country responds in anger and frustration to the latest mass shooting and Disney shocks the industry with ouster of CEO.

Source: laist.com
Huntington: Giving Tuesday volunteer event at Village Closet - Vimarsana News

Huntington: Giving Tuesday volunteer event at Village Closet

The Village Closet, a donation center offering baby and children’s clothing, diapers and other essential supplies, will celebrate Giving Tuesday by hosting a volunteer event from 10 a.m. to 8

The chain reaction of postpartum depression on the family: how to break the cycle - Vimarsana News

The chain reaction of postpartum depression on the family: how to break the cycle

Postpartum Depression isn’t just a mother's problem, it can affect the whole family. How does postpartum depression affect the baby? Is PPD hereditary? Who experiences postpartum depression? Why do dads get postpartum depression? What causes postpartum depression? What’s the difference between postpartum depression and the ‘baby blues?’

Sage Therapeutics and Biogen Announce that the Phase 3 SKYLARK Study of Zuranolone in Postpartum Dep - Vimarsana News

Sage Therapeutics and Biogen Announce that the Phase 3 SKYLARK Study of Zuranolone in Postpartum Dep

Zuranolone 50 mg demonstrated a statistically significant and clinically meaningful improvement in depressive symptoms at Day 15, the primary endpoint, and at Days 3, 28, and 45, key secondary endpointsZuranolone 50 mg was generally well-tolerated and demonstrated a safety profile consistent with prior studiesPostpa...